Background: The Pierde Peso, Gana Vida (Lose Weight, Gain Life) strategy is granted to patients with overweight or obesity, it started in 2022 with the purpose of ordering, integrating and making efficient actions in the care of overweight and obesity, however, its effectiveness is unknown.
Objective: To analyze the changes in the following parameters: body weight, waist circumference, glucose, cholesterol and triglycerides in patients who received the strategy in the 35 IMSS state offices during the two semesters of 2022.
Material And Methods: A retrospective cohort study was conducted including 76,760 patients incorporated into the strategy in the two semesters of 2022. Trend analysis was performed before and after each semester of intervention. Analytical statistics were used for related samples with Student's t-test. SPPSS v25 software was used for data analysis.
Results: Patients who received this strategy in each semester presented significant decrease in the parameters: body weight, waist circumference, glucose, cholesterol and triglycerides.
Conclusions: The Pierde Peso, Gana Vida strategy makes the actions in obesity care efficient and allows achieving good results in the beneficiaries.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5281/zenodo.13306787 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[The Pierde Kilos, Gana Vida strategy, scope and prospects].
Rev Med Inst Mex Seguro Soc
November 2024
Instituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas, Unidad de Atención Médica, Coordinación de Unidades de Primer Nivel, División de Promoción a la Salud. Ciudad de México, México.
Background: The Pierde Peso, Gana Vida (Lose Weight, Gain Life) strategy is granted to patients with overweight or obesity, it started in 2022 with the purpose of ordering, integrating and making efficient actions in the care of overweight and obesity, however, its effectiveness is unknown.
Objective: To analyze the changes in the following parameters: body weight, waist circumference, glucose, cholesterol and triglycerides in patients who received the strategy in the 35 IMSS state offices during the two semesters of 2022.
Material And Methods: A retrospective cohort study was conducted including 76,760 patients incorporated into the strategy in the two semesters of 2022.
Antibacterial activity of a complex bacteriocin secreted by Staphylococcus epidermidis against Porphyromonas gingivalis.
Arch Oral Biol
August 2023
Laboratorio de Microbiología y Biotecnología Oral, Facultad de Ciencias de la Vida, Universidad Andres Bello, Echaurren 237, 8370133 Santiago, Chile; Facultad de Odontología, Universidad Andres Bello, Echaurren 237, Santiago 8370133, Chile. Electronic address:
Objective: To characterize the inhibitory activity of a novel bacteriocin produced by Staphylococcus epidermidis against this periodontal pathogen.
Design: The bacteriocin activity was evaluated by the agar diffusion method over a lawn of P. gingivalis ATCC 33277.
Antioxidant activity and enzymatic of lichen substances: A study based on cyclic voltammetry and theoretical.
Chem Biol Interact
February 2023
Facultad de Ciencias Naturales y Matemáticas, Universidad de Ibagué, Carrera 22 Calle 67, Ibagué, 730002, Colombia; Centro Integrativo de Biología y Química Aplicada (CIBQA), Universidad Bernardo O'Higgins, General Gana 1702, Santiago, 8370854, Chile. Electronic address:
The antioxidant activity of nine lichen substances, including methylatrarate (1), methyl haematommate (2), lobaric acid (3), fumarprotocetraric acid (4), sphaerophorin (5), subsphaeric acid (6), diffractaic acid (7), barbatolic acid (8) and salazinic acid (9) has been determined through cyclic voltammetry. The compounds 1-4 presented slopes close to the Nernst constant of 0.059 V, indicating a 2H/2e relation between protons and electrons, as long as the compounds 5, 6, 7, 8, and 9 present slopes between 0.
View Article and Find Full Text PDFSearch for Novel Potent Inhibitors of the SARS-CoV-2 Papain-like Enzyme: A Computational Biochemistry Approach.
Pharmaceuticals (Basel)
August 2022
Center for Bioinformatics and Integrative Biology (CBIB), Facultad de Ciencias de la Vida, Universidad Andres Bello, Av. República 330, Santiago 8370146, Chile.
The rapid emergence and spread of new variants of coronavirus type 2, as well as the emergence of zoonotic viruses, highlights the need for methodologies that contribute to the search for new pharmacological treatments. In the present work, we searched for new SARS-CoV-2 papain-like protease inhibitors in the PubChem database, which has more than 100 million compounds. Based on the ligand efficacy index obtained by molecular docking, 500 compounds with higher affinity than another experimentally tested inhibitor were selected.
View Article and Find Full Text PDFTaxonomic changes suggested by the genomic analysis of Hesperiidae (Lepidoptera).
Insecta mundi
February 2022
Howard Hughes Medical Institute and Departments of Biophysics and Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390-9050 USA.
Our expanded efforts in genomic sequencing to cover additional skipper butterfly (Lepidoptera: Hesperiidae) species and populations, including primary type specimens, call for taxonomic changes to restore monophyly and correct misidentifications by moving taxa between genera and proposing new names. Reconciliation between phenotypic characters and genomic trees suggests three new tribes, two new subtribes, 23 new genera, 17 new subgenera and 10 new species that are proposed here: Psolosini Grishin, (type genus Staudinger, 1889), Ismini Grishin, (type genus Distant, 1886), Eetionini Grishin, (type genus de Nicéville, 1895), Orphina Grishin, (type genus Godman, 1901), Carystoidina Grishin, (type genus Godman, 1901), Grishin, (type species Plötz, 1882), Grishin, (type species Mabille and Boullet, 1912), Grishin, (type species Grishin, ), Grishin, (type species Plötz, 1884), Grishin, (type species Evans, 1937), Grishin, (type species Trimen, 1873), Grishin, (type species Hayward, 1951), Grishin, (type species Mabille, 1889), Grishin, (type species ? Schaus, 1913), Grishin, (type species Schaus, 1902), Grishin, (type species Schaus, 1902), Grishin, (type species Godman, 1900), Grishin, (type species Bell, 1937), Grishin, (type species Bell, 1932), Grishin, (type species Plötz, 1882), Grishin, (type species Bell, 1930), Grishin, (type species Bell, 1930), Grishin, (type species Bell, 1932), Grishin, (type species Lindsey, 1925), Grishin, (type species Hewitson, 1877), Grishin, (type species Godman, 1900), Grishin, (type species Hewitson, 1866), Grishin, (type species Hewitson, 1878), Grishin, (type species Evans, 1952), Grishin, (type species Cramer, 1780), Grishin, (type species Plötz, 1884), Grishin, (type species Plötz, 1884), Grishin, (type species Evans, 1928), Grishin, (type species Herrich-Schäffer, 1869), Grishin, (type species Mabille, 1891), Grishin, (type species [sic] Schaus, 1913), Grishin, (type species Godman, 1900), Grishin, (type species Möschler, 1879), Grishin, (type species Mielke and Casagrande, 2002), Grishin, (type species Godman, 1901), Grishin, (type species Schaus, 1902), Grishin, (type species Evans, 1955), Grishin, (type species Evans, 1955), Grishin, (type species Godman, 1900), Grishin, (type species Evans, 1955), Grishin, (type locality in Brazil: Santa Catarina), Grishin, (type locality in Guyana: Acarai Mts.), Grishin, (type locality in Paraguay: Sapucay), Grishin, (type locality in Brazil: Rondônia), Grishin, (type locality in Ecuador: Riobamba), Grishin, (type locality in Colombia: Bogota), Grishin, (type locality in Panama: Colón), Grishin, (type locality in Nicaragua: Chontales), Grishin, (type locality in Peru: Cuzco), and Grishin, (type locality in Costa Rica).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!